Detalhe da pesquisa
1.
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.
Proc Natl Acad Sci U S A
; 110(32): E2987-96, 2013 Aug 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23882082
2.
Hepatocyte growth factor (HGF) autocrine activation predicts sensitivity to MET inhibition in glioblastoma.
Proc Natl Acad Sci U S A
; 109(2): 570-5, 2012 Jan 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22203985
3.
HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.
Neoplasia
; 8(5): 344-52, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16790083
4.
In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.
Neoplasia
; 8(5): 353-63, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16790084